LY 264826与万古霉素针对100株耐甲氧西林金黄色葡萄球菌临床分离株及100株艰难梭菌临床分离株的体外活性比较。
In vitro activity of LY 264826 compared with that of vancomycin against 100 clinical isolates each of methicillin-resistant Staphylococcus aureus and Clostridium difficile.
作者信息
Fasola E L, Moody J A, Gerding D N, Peterson L R
机构信息
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis 55417.
出版信息
Antimicrob Agents Chemother. 1990 Oct;34(10):2007-8. doi: 10.1128/AAC.34.10.2007.
Abstract
The in vitro activity of LY 264826, a new glycopeptide antibiotic, was compared with that of vancomycin against 100 strains each of methicillin-resistant Staphylococcus aureus and Clostridium difficile. LY 264826 was more active, by weight, than vancomycin against the isolates tested. The human serum protein binding of LY 264826 was 15.3% (range, 9.8 to 21.8%).
摘要
将新型糖肽类抗生素LY 264826的体外活性与万古霉素针对100株耐甲氧西林金黄色葡萄球菌和艰难梭菌的活性进行了比较。按重量计算，LY 264826对所测试的分离菌株的活性高于万古霉素。LY 264826与人血清蛋白的结合率为15.3%（范围为9.8%至21.8%）。
相似文献
1
In vitro activity of LY 264826 compared with that of vancomycin against 100 clinical isolates each of methicillin-resistant Staphylococcus aureus and Clostridium difficile.LY 264826与万古霉素针对100株耐甲氧西林金黄色葡萄球菌临床分离株及100株艰难梭菌临床分离株的体外活性比较。
Antimicrob Agents Chemother. 1990 Oct;34(10):2007-8. doi: 10.1128/AAC.34.10.2007.
2
Activity of a novel cyclic lipopeptide, CB-183,315, against resistant Clostridium difficile and other Gram-positive aerobic and anaerobic intestinal pathogens.新型环状脂肽 CB-183,315 对耐药性艰难梭菌和其他革兰氏阳性需氧和厌氧肠道病原体的活性。
Antimicrob Agents Chemother. 2012 Jun;56(6):3448-52. doi: 10.1128/AAC.06257-11. Epub 2012 Mar 5.
3
Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B.新型半合成糖肽类抗生素，对耐甲氧西林金黄色葡萄球菌（MRSA）和耐万古霉素肠球菌（VRE）具有活性：氯东方霉素B的双修饰水溶性衍生物。
Bioorg Med Chem Lett. 2002 Nov 4;12(21):3027-31. doi: 10.1016/s0960-894x(02)00664-9.
4
Balhimycin, a new glycopeptide antibiotic produced by Amycolatopsis sp. Y-86,21022. Taxonomy, production, isolation and biological activity.巴尔他霉素，一种由拟无枝酸菌属Y-86,21022产生的新型糖肽抗生素。分类学、生产、分离及生物活性
J Antibiot (Tokyo). 1994 Mar;47(3):334-41. doi: 10.7164/antibiotics.47.334.
5
Intracellular activity of vancomycin and Ly333328, a new semisynthetic glycopeptide, against methicillin-resistant Staphylococcus aureus.万古霉素和新型半合成糖肽Ly333328对耐甲氧西林金黄色葡萄球菌的细胞内活性。
Infection. 1998 May-Jun;26(3):165-7. doi: 10.1007/BF02771843.
6
Interactions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility.耐甲氧西林金黄色葡萄球菌菌株中，甲氧西林与万古霉素之间的相互作用表现出不同的万古霉素敏感性表型。
J Clin Microbiol. 1999 Sep;37(9):3068-71. doi: 10.1128/JCM.37.9.3068-3071.1999.
7
In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.雷莫拉宁和四种糖肽类抗生素对艰难梭菌临床分离株的体外活性
Antimicrob Agents Chemother. 1991 Jan;35(1):195-7. doi: 10.1128/AAC.35.1.195.
8
Evaluation of apramycin activity against methicillin-resistant, methicillin-sensitive, and vancomycin-intermediate Staphylococcus aureus clinical isolates.对庆大霉素对耐甲氧西林金黄色葡萄球菌、甲氧西林敏感金黄色葡萄球菌和万古霉素中介金黄色葡萄球菌临床分离株的活性评估。
Diagn Microbiol Infect Dis. 2018 Oct;92(2):168-171. doi: 10.1016/j.diagmicrobio.2018.05.018. Epub 2018 May 29.
9
In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis.头孢吡肟与万古霉素对甲氧西林敏感及耐药金黄色葡萄球菌和表皮葡萄球菌的体外协同作用。
J Antimicrob Chemother. 2001 Jan;47(1):83-6. doi: 10.1093/jac/47.1.83.
10
Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium.新型糖肽类药物LY333328的药效学评价及其对金黄色葡萄球菌和粪肠球菌的体外活性
Antimicrob Agents Chemother. 1997 Jun;41(6):1307-12. doi: 10.1128/AAC.41.6.1307.
引用本文的文献
1
In vitro activity of the new glycopeptide LY264826 versus vancomycin against clinical isolates of enterococci.新型糖肽类药物LY264826与万古霉素对肠球菌临床分离株的体外活性比较
Eur J Clin Microbiol Infect Dis. 1991 Nov;10(11):982-3. doi: 10.1007/BF02005460.
本文引用的文献
1
Assay of 27 antimicrobials using a microbiological method.
Minn Med. 1983 May;66(5):321-4.
2
Standardization of a preparative ultracentrifuge method for quantitative determination or protein binding of seven antibiotics.
J Infect Dis. 1977 Dec;136(6):778-83. doi: 10.1093/infdis/136.6.778.
Zotero 插件